Gefapixant Impurity 3 | CAS 1015787-97-9 - Request Quote
Gefapixant Impurity 3
| SZ CAT No: | SZ-G064004 |
| CAS No | 1015787-97-9 |
| Mol.F. | C14H18N4O5S |
| Mol.Wt. | 354.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gefapixant Impurity 3 is chemically 5-((2,Diaminopyrimidin-5-yl)oxy)-4-isopropyl-2-methoxybenzenesulfonic acid. Gefapixant Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Gefapixant Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefapixant.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1015787-97-9
Purchase 1015787-97-9
Order 1015787-97-9
Enquire 1015787-97-9
price of 1015787-97-9
1015787-97-9 Supplier
1015787-97-9 Manufacturer
1015787-97-9 Exporter
buy high quality Gefapixant Impurity 3
Purchase Gefapixant Impurity 3
Gefapixant Impurity 3 suppliers
Gefapixant Impurity 3 manufacturers
Gefapixant Impurity 3 price
Order Gefapixant Impurity 3
Enquire Gefapixant Impurity 3
Gefapixant Impurity 3 cost
Gefapixant Impurity 3 Supplier
Gefapixant Impurity 3 Distributor
Gefapixant Impurity 3 for Method Validation
Gefapixant Reference Standard
Gefapixant Impurity 3 for ANDA Filing
Gefapixant Impurity 3 for Forced Degradation Studies
Gefapixant Impurity 3 Identification Standards
Gefapixant Impurity 3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.